FDA recall, , Moderate risk
Major Pharmaceuticals Levothyroxine Sodium Tablets
Levothyroxine Sodium Tablets are subpotent.
Summary by Recall Canary from the FDA notice
What happened
Major Pharmaceuticals, of Dublin, Ohio, recalled Levothyroxine Sodium Tablets because the drug is subpotent. The recall began July 13, 2026, and was added to the FDA's Enforcement Report on July 17, 2026. The tablets were distributed nationwide in the USA.
5 photos
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare the details below with your product and check the FDA notice to confirm whether it is affected.
An NDC (National Drug Code) is usually printed on the drug's label.
Levothyroxine Sodium Tablets, USP
- Strength
- 75 mcg
- Lot code
- N02172A
- N02172B
- N02172
- Strength
- 150 mcg
- Lot code
- N02167A
- N02167
- Strength
- 88 mcg
- NDC
- 0904-6952-61
- Lot code
- N02310
- Strength
- 75 mcg
- NDC
- 0904-6951-61
- Lot code
- N02172
- Strength
- 125 mcg
- Lot code
- N02266A
- N02266B
- N02266
- Strength
- 25 mcg
- NDC
- 0904-6949-61
- Lot code
- N02212
- Strength
- 50 mcg
- NDC
- 0904-6950-61
- Lot code
- N02200
- Strength
- 125 mcg
- NDC
- 0904-6955-61
- Lot code
- N02266
- Strength
- 25 mcg
- Lot code
- N02212A
- N02212B
- N02212
- Strength
- 112 mcg
- NDC
- 0904-6954-61
- Lot code
- N02203
- Strength
- 150 mcg
- NDC
- 0904-6956-61
- Lot code
- N02167
- Strength
- 50 mcg
- Lot code
- N02200A
- N02200B
- N02200
Some entries omit identifying details. Check the notice to confirm which units are affected.
Recall details
- Company began the recall
- Sold in
Nationwide in the USA.
- Company
- Major PharmaceuticalsDublin, Ohio
- Hazard
- Wrong drug strength
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 99399
- Recall numbers
- D-0700-2026 to D-0711-2026
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA
Listed on Recall Canary
In FDA's weekly enforcement report
Summary updated
